Quantcast

Latest ovarian cancer Stories

2014-06-02 08:30:18

SEATTLE, June 2, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY) today announced the presentation of data from a Phase 1 trial of ONT-10, an antigen-specific immunotherapy targeting MUC1, at the American Association of Clinical Oncology (ASCO) 2014 Annual Meeting in Chicago. The data demonstrated that ONT-10 was well tolerated in this trial, resulted in a humoral immune response in the majority of patients and led to encouraging disease control in advanced stage patients with...

2014-06-01 12:20:16

Diagnostic insights into gene mutations in solid tumor cancers will aid therapy selection and prognosis for patients and advance research NEW YORK and MADISON, N.J., June 1, 2014 /PRNewswire/ -- Memorial Sloan Kettering Cancer Center, the world's oldest and largest private cancer center, and Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced a joint collaboration that will utilize MSK's clinical and research insights into...

2014-05-31 08:20:38

Clinical Studies in Gynecologic Cancers Confirm the Unique Clinical Utility of Caris Molecular Intelligence(TM) CHICAGO, May 31, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of precision medicine, announced today the presentation of clinical data from studies demonstrating the potential utility of comprehensive molecular profiling in guiding treatment of patients with gynecologic malignancies, including breast cancers and ovarian...

2014-05-29 23:14:13

Colleen’s Dream Foundation has gifted $10,000 to Hollings Cancer Center at the Medical University of South Carolina to fund ovarian cancer research being conducted by Dr. Hiu Wing Cheung, according to Colleen’s Dream Foundation President Billy Cundiff. Phoenix, AZ (PRWEB) May 29, 2014 Colleen’s Dream Foundation has gifted $10,000 to Hollings Cancer Center at the Medical University of South Carolina to fund ovarian cancer research being conducted by Dr. Hiu Wing Cheung, according to...

2014-05-28 12:31:30

LONDON, May 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Ovarian Cancer - Pipeline Review, H1 2014http://www.reportbuyer.com/pharma_healthcare/research_r_d/pipeline/ovarian_cancer.html Ovarian Cancer - Pipeline Review, H1 2014 SummaryGlobal Markets Direct's, 'Ovarian Cancer - Pipeline Review, H1 2014', provides an overview of the Ovarian Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic development...

breast cancer double mastectomy
2014-05-22 11:34:51

Brett Smith for redOrbit.com - Your Universe Online One year ago last week, Angelina Jolie announced in a New York Times op-ed that she had undergone a preventative double mastectomy – but now a new study indicates that surgically removing both breasts may be unnecessary for women who are diagnosed with cancer in a single breast. Published in the journal JAMA Surgery, the new study found that approximately 70 percent of women that have both breasts removed after having a breast cancer...

2014-05-21 12:04:38

University of Melbourne Researchers have identified nine simple questions that can be used to identify people who may be at increased risk of various cancers, heart disease and diabetes because of their family history of these conditions. The family history screening questionnaire can be used to provide insight into people’s susceptibility to breast, ovarian, bowel and prostate cancer, melanoma, ischaemic heart disease and type 2 diabetes. These findings will lead to greater...

2014-05-20 23:02:55

New comprehensive research report “Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies” elaborated by GBI Research is now available at MarketPublishers.com. According to the study, the global ovarian cancer therapeutics market is anticipated to post a 3.4% CAGR through 2020. London, UK (PRWEB) May 20, 2014 At present, the overall ovarian cancer therapeutics market is led by the use of...

2014-05-19 23:02:53

Transparency Market Research Report Added "Adjuvants Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2012 - 2018" to its database. Browse Full Report: http://www.transparencymarketresearch.com/adjuvants-market.html. Albany, New York, USA (PRWEB) May 19, 2014 Adjuvant oncology treatment comprises of a class of cancer therapeutics which is followed after primary cancer treatment, to minimize the risk of reoccurrence of cancer. The major forms of...

2014-05-19 08:27:27

ROCKVILLE, Md., May 19, 2014 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, announced today two poster presentations on ENMD-2076 at the American Society of Clinical Oncology Annual Meeting for two of its trials currently in progress. ENMD-2076 is currently in Phase 2 advanced soft tissue sarcoma and Phase 2 ovarian clear cell carcinoma, trials at Princess Margaret Cancer...


Latest ovarian cancer Reference Libraries

Ovaries
2013-03-05 14:55:04

The ovaries are the two reproductive female organs where the eggs are produced. These are parallel to the testes in men. Formation and Orientation Each ovary is the size of an almond and is located on one side of the pelvis before the ureter and internal iliac artery but after the external iliac artery. They are attached to either side of the uterus. They are connected and release eggs to fallopian tubes, though not attached, monthly during the menstrual cycle. They also produce...

More Articles (1 articles) »
Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related